Spann W, Wolfram G, Zöllner N
Klin Wochenschr. 1987 Jul 1;65(13):590-5. doi: 10.1007/BF01726664.
Polyenylphosphatidylcholine was given orally in a dosage of 10 g per day to 10 healthy subjects for 4 weeks. The concentrations of cholesterol, triglycerides, phospholipids, apolipoproteins AI, AII, and B were measured in serum, as were very low density lipoproteins, low density lipoproteins, and high density lipoproteins every 3 h on the day before and after the 4 weeks of application. The diet was controlled 10 days before and during the experiment using the dietary recall method. The evaluation of the diet records showed that 5 subjects had increased and 5 subjects had decreased their fat consumption in exchange for carbohydrates during the experiment. Nevertheless body weight remained constant within +/- 1 kg. Cholesterol in serum and low density lipoprotein decreased, but the differences were not statistically significant. In spite of dietary changes apolipoprotein AI and AII in high density lipoproteins increased significantly. We conclude that the influence of drugs on serum lipids can only be evaluated in conjunction with reliable control of the diet.
将多烯磷脂酰胆碱以每天10克的剂量口服给予10名健康受试者,持续4周。在应用4周前后的当天,每3小时测量血清中胆固醇、甘油三酯、磷脂、载脂蛋白AI、AII和B的浓度,以及极低密度脂蛋白、低密度脂蛋白和高密度脂蛋白的浓度。在实验前10天和实验期间,采用饮食回顾法控制饮食。对饮食记录的评估显示,在实验期间,5名受试者增加了脂肪摄入量,5名受试者减少了脂肪摄入量,转而摄入碳水化合物。然而,体重在±1千克范围内保持恒定。血清胆固醇和低密度脂蛋白有所下降,但差异无统计学意义。尽管饮食发生了变化,高密度脂蛋白中的载脂蛋白AI和AII仍显著增加。我们得出结论,只有在可靠控制饮食的情况下,才能评估药物对血脂的影响。